Pflug Koory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $235K | Hold |
1,857
| – | – | 0.09% | 149 |
|
|
2026
Q1 | $259K | Sell |
1,857
-105
| -5% | -$14.7K | 0.12% | 140 |
|
|
2025
Q4 | $241K | Hold |
1,962
| – | – | 0.11% | 146 |
|
|
2025
Q3 | $218K | Hold |
1,962
| – | – | 0.1% | 150 |
|
|
2025
Q2 | $218K | Hold |
1,962
| – | – | 0.11% | 145 |
|
|
2025
Q1 | $220K | Sell |
1,962
-181
| -8% | -$18.7K | 0.12% | 143 |
|
|
2024
Q4 | $198K | Buy |
2,143
+150
| +8% | +$13.5K | 0.1% | 151 |
|
|
2024
Q3 | $167K | Buy |
+1,993
| New | +$152K | 0.08% | 161 |
|
|
2024
Q1 | $148K | Sell |
2,020
-5
| -0.2% | -$384 | 0.07% | 169 |
|
|
2023
Q4 | $164K | Hold |
2,025
| – | – | 0.09% | 159 |
|
|
2023
Q3 | $152K | Hold |
2,025
| – | – | 0.09% | 158 |
|
|
2023
Q2 | $156K | Hold |
2,025
| – | – | 0.08% | 169 |
|
|
2023
Q1 | $168K | Sell |
2,025
-100
| -5% | -$8.28K | 0.09% | 158 |
|
|
2022
Q4 | $182K | Sell |
2,125
-95
| -4% | -$7.52K | 0.1% | 153 |
|
|
2022
Q3 | $137K | Hold |
2,220
| – | – | 0.08% | 170 |
|
|
2022
Q2 | $137K | Sell |
2,220
-100
| -4% | -$6.19K | 0.08% | 174 |
|
|
2022
Q1 | $138K | Sell |
2,320
-375
| -14% | -$24K | 0.07% | 185 |
|
|
2021
Q4 | $196K | Hold |
2,695
| – | – | 0.1% | 163 |
|
|
2021
Q3 | $188K | Sell |
2,695
-500
| -16% | -$35.1K | 0.1% | 162 |
|
|
2021
Q2 | $220K | Buy |
3,195
+500
| +19% | +$33.4K | 0.12% | 160 |
|
|
2021
Q1 | $174K | Sell |
2,695
-638
| -19% | -$41.1K | 0.1% | 168 |
|
|
2020
Q4 | $194K | Sell |
3,333
-490
| -13% | -$29.6K | 0.11% | 163 |
|
|
2020
Q3 | $242K | Buy |
3,823
+250
| +7% | +$17.3K | 0.16% | 126 |
|
|
2020
Q2 | $275K | Hold |
3,573
| – | – | 0.2% | 111 |
|
|
2020
Q1 | $267K | Hold |
3,573
| – | – | 0.24% | 102 |
|
|
2019
Q4 | $232K | Buy |
3,573
+25
| +0.7% | +$1.63K | 0.16% | 136 |
|
|
2019
Q3 | $225K | Buy |
3,548
+65
| +2% | +$4.25K | 0.17% | 136 |
|
|
2019
Q2 | $235K | Sell |
3,483
-260
| -7% | -$17.1K | 0.18% | 131 |
|
|
2019
Q1 | $243K | Sell |
3,743
-125
| -3% | -$8.31K | 0.19% | 129 |
|
|
2018
Q4 | $242K | Sell |
3,868
-1,250
| -24% | -$87.4K | 0.21% | 118 |
|
|
2018
Q3 | $395K | Sell |
5,118
-280
| -5% | -$21.1K | 0.32% | 93 |
|
|
2018
Q2 | $382K | Hold |
5,398
| – | – | 0.3% | 96 |
|
|
2018
Q1 | $407K | Sell |
5,398
-100
| -2% | -$7.95K | 0.34% | 91 |
|
|
2017
Q4 | $394K | Hold |
5,498
| – | – | 0.31% | 105 |
|
|
2017
Q3 | $445K | Buy |
5,498
+150
| +3% | +$11.5K | 0.36% | 89 |
|
|
2017
Q2 | $379K | Buy |
5,348
+415
| +8% | +$27.6K | 0.32% | 94 |
|
|
2017
Q1 | $335K | Buy |
4,933
+875
| +22% | +$61.5K | 0.29% | 101 |
|
|
2016
Q4 | $291 | Buy |
+4,058
| New | +$302K | 0.25% | 109 |
|
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
Pflug Koory's GILD Position: Q2 2026 in Review
Pflug Koory held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,857 shares worth $235K. The position accounts for 0.09% of the portfolio, ranked #149.
Pflug Koory first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $445K in Q3 2017. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pflug Koory held 1,857 shares of Gilead Sciences worth $235K as of Q2 2026.
- Pflug Koory left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.09% of Pflug Koory's portfolio in Q2 2026, its #149 holding.
- Pflug Koory first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- Pflug Koory's Gilead Sciences position peaked at $445K in Q3 2017.
- 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.